UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 23, 2017
Accession Number:
0001144204-17-052860
Submission Type:
POS AM
CIK:
0001659617
Company Name:
Moleculin Biotech, Inc.
File Number:
333-214898